nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.0236	0.0236	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.0229	0.0229	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0192	0.0192	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0188	0.0188	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0187	0.0187	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0186	0.0186	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0184	0.0184	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0182	0.0182	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0164	0.0164	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0161	0.0161	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0161	0.0161	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0157	0.0157	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.0149	0.0149	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.013	0.013	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0127	0.0127	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0125	0.0125	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0122	0.0122	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0122	0.0122	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.012	0.012	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0114	0.0114	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0111	0.0111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0111	0.0111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0109	0.0109	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0106	0.0106	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0105	0.0105	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0103	0.0103	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0103	0.0103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0102	0.0102	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0101	0.0101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.01	0.01	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00994	0.00994	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00985	0.00985	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00974	0.00974	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00973	0.00973	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00956	0.00956	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00953	0.00953	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00936	0.00936	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00926	0.00926	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00906	0.00906	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00906	0.00906	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00886	0.00886	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00877	0.00877	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00862	0.00862	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00858	0.00858	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00851	0.00851	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00849	0.00849	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00844	0.00844	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00839	0.00839	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00833	0.00833	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00831	0.00831	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00821	0.00821	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00793	0.00793	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00776	0.00776	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.0075	0.0075	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00742	0.00742	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00734	0.00734	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00726	0.00726	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00706	0.00706	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00692	0.00692	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00691	0.00691	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0069	0.0069	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00677	0.00677	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00675	0.00675	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00668	0.00668	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00656	0.00656	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00654	0.00654	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00648	0.00648	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00648	0.00648	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00643	0.00643	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00641	0.00641	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00635	0.00635	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00635	0.00635	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00628	0.00628	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00628	0.00628	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00615	0.00615	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00604	0.00604	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00591	0.00591	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00565	0.00565	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00556	0.00556	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00553	0.00553	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00544	0.00544	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0048	0.0048	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00469	0.00469	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00441	0.00441	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00436	0.00436	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00432	0.00432	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00426	0.00426	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00423	0.00423	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00419	0.00419	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00414	0.00414	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0041	0.0041	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0039	0.0039	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00381	0.00381	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00381	0.00381	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00379	0.00379	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00377	0.00377	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00373	0.00373	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00371	0.00371	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00371	0.00371	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00371	0.00371	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00369	0.00369	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00366	0.00366	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00364	0.00364	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00363	0.00363	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00363	0.00363	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00359	0.00359	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00356	0.00356	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00354	0.00354	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00346	0.00346	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00343	0.00343	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00341	0.00341	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00337	0.00337	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00335	0.00335	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00334	0.00334	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00333	0.00333	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0033	0.0033	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00326	0.00326	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0031	0.0031	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00303	0.00303	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00257	0.00257	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00252	0.00252	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00239	0.00239	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00234	0.00234	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00225	0.00225	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.0022	0.0022	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00217	0.00217	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00212	0.00212	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00209	0.00209	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00205	0.00205	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00202	0.00202	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00199	0.00199	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00198	0.00198	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00197	0.00197	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00195	0.00195	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00192	0.00192	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00183	0.00183	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00179	0.00179	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00128	0.00128	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00126	0.00126	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000679	0.000679	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000665	0.000665	CbGpPWpGaD
